Bridging communities in the field of nanomedicine

An early dialogue between nanomedicine developers and regulatory authorities are of utmost importance to anticipate quality and safety requirements for these innovative health products. In order to stimulate interactions between the various communities involved in a translation of nanomedicines to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Halamoda-Kenzaoui, Blanka, Baconnier, Simon, Bastogne, Thierry, Bazile, Didier, Boisseau, Patrick, Borchard, Gerrit, Borgos, Sven Even, Calzolai, Luigi, Cederbrant, Karin, Di Felice, Gabriella, Di Francesco, Tiziana, Dobrovolskaia, Marina A., Gaspar, Rogério, Gracia, Belén, Hackley, Vincent A., Leyens, Lada, Liptrott, Neill, Park, Margriet, Patri, Anil, Roebben, Gert, Roesslein, Matthias, Thürmer, René, Urbán, Patricia, Zuang, Valérie, Bremer-Hoffmann, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597901/
https://www.ncbi.nlm.nih.gov/pubmed/31051191
http://dx.doi.org/10.1016/j.yrtph.2019.04.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597901/
https://www.ncbi.nlm.nih.gov/pubmed/31051191
http://dx.doi.org/10.1016/j.yrtph.2019.04.011

Ejemplares similares